Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Heger

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Circulation|July 1, 1990
Clinical features of amiodarone-induced pulmonary toxicityR E Dusman, M S Stanton, W M Miles, et al.
The New England Journal of Medicine|September 3, 1981
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillationJ J Heger, E N Prystowsky, W M Jackman, et al.
Circulation|February 1, 1983
Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atrioventricular nodal physiologyW M Jackman, E N Prystowsky, G V Naccarelli, et al.
The American Journal of Cardiology|May 1, 1988
Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic studyL S Klein, N Fineberg, J J Heger, et al.
The American Journal of Medicine|November 1, 1982
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncopeS Gulamhusein, G V Naccarelli, P T Ko, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndromeW M Miles, D P Zipes, R L Rinkenberger, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndromeR L Rinkenberger, G V Naccarelli, W M Miles, et al.
American Heart Journal|May 1, 1982
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrodeD P Zipes, W M Jackman, J J Heger, et al.
American Heart Journal|January 1, 1993
Five-year follow-up of 589 patients treated with amiodaroneB A Weinberg, W M Miles, L S Klein, et al.
Journal of the American College of Cardiology|November 15, 1989
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidineM S Stanton, M M Tuli, N L Radtke, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Circulation|July 1, 1990
Clinical features of amiodarone-induced pulmonary toxicityR E Dusman, M S Stanton, W M Miles, et al.
The New England Journal of Medicine|September 3, 1981
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillationJ J Heger, E N Prystowsky, W M Jackman, et al.
Circulation|February 1, 1983
Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atrioventricular nodal physiologyW M Jackman, E N Prystowsky, G V Naccarelli, et al.
The American Journal of Cardiology|May 1, 1988
Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic studyL S Klein, N Fineberg, J J Heger, et al.
The American Journal of Medicine|November 1, 1982
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncopeS Gulamhusein, G V Naccarelli, P T Ko, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndromeW M Miles, D P Zipes, R L Rinkenberger, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndromeR L Rinkenberger, G V Naccarelli, W M Miles, et al.
American Heart Journal|May 1, 1982
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrodeD P Zipes, W M Jackman, J J Heger, et al.
American Heart Journal|January 1, 1993
Five-year follow-up of 589 patients treated with amiodaroneB A Weinberg, W M Miles, L S Klein, et al.
Journal of the American College of Cardiology|November 15, 1989
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidineM S Stanton, M M Tuli, N L Radtke, et al.
Pageof 7